Stephen Cho

All articles by Stephen Cho

Hematologic Cancers

Comorbidities Predict Inferior Survival in Patients Receiving CAR T-Cell Therapy

December 9, 2019

With Adam Kittai, MD

Multiple Myeloma

Daratumumab Maintenance Therapy Improves Depth of Response and Results in Durable PFS

December 9, 2019

With Robert Rifkin, MD, FACP

Hematologic Cancers

RP-L102, a Potential Gene Therapy for Fanconi Anemia

December 8, 2019

With Gaurav Shah, MD

Hematologic Cancers

A Data-Driven Database With Synthetic Controls for Hematology Clinical Research Development

December 8, 2019

With Bryant Fields

Dose Optimization of Duvelisib in Patients With R/R Peripheral T-Cell Lymphoma

December 8, 2019

With Steven M. Horwitz, MD

Tisagenlecleucel CAR T-Cell Therapy for Adults With DLBCL

December 8, 2019

With Samantha Jaglowski, MD

Hematologic Cancers

Daratumumab Plus Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone

December 8, 2019

With Nizar Bahlis, MD

Hematologic Cancers

ZUMA-1: Three-Year Survival Data

December 8, 2019

With Max S. Topp, MD

Multiple Myeloma

Depth of Response to Daratumumab, Lenalidomide, Bortezomib and Dexamethasone Improves Over Time

December 8, 2019

With Peter M. Voorhees, MD

Chronic Lymphocytic Leukemia

Updates From the Phase III MURANO Study

December 7, 2019

With John Seymour, MD, PhD

Next post in Chronic Lymphocytic Leukemia

Phase I Study of Duvelisib and Venetoclax in Patients With Relapsed or Refractory CLL / SLL